Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 16: 39-41, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004110955
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pontremoli, R.
Right arrow Articles by Deferrari, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pontremoli, R.
Right arrow Articles by Deferrari, G.

Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension

Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo Deferrari

Section of Nephrology, Department of Internal Medicine, University of Genoa, Genoa, Italy

Address correspondence to: Dr. Roberto Pontremoli, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6-16132 Genoa, Italy. Phone and Fax: +39-010-353-8932; EMAIL: roberto.pontremoli{at}unige.it

Accurate cardiovascular risk evaluation is a prerequisite for devising cost-effective therapeutic strategies in patients with essential hypertension. In fact, the knowledge of concomitant risk factors, diabetes, target organ damage, or associated clinical conditions may be useful when deciding both treatment and BP goals. Thorough evaluation of target organ damage is the key to sensitive assessment of global risk, but cost-effective allocation of economic resources should also be taken into consideration. Thanks to its low cost and widespread availability, the search for microalbuminuria is a first-line tool for identifying hypertensive patients who are at higher cardiovascular risk.




This article has been cited by other articles:


Home page
 Cleveland Clinic Journal of MedicineHome page
R. KATAKAM, K. BRUKAMP, and R. R. TOWNSEND
What is the proper workup of a patient with hypertension?
Cleveland Clinic Journal of Medicine, September 1, 2008; 75(9): 663 - 672.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Zhu, Y. Liu, L. Wang, and Q. H. Meng
Transforming growth factor-{beta}1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2841 - 2846.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673